Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

TAVR in Small Annuli: Is There a Better Valve?

Transcatheter aortic valve replacement with the self-expandable valves has shown optimal clinical and electrocardiographic results in patients with small annuli. These supra-annular prosthetic valves seem somewhat better than the intra-annular balloon expandable. 

tavi calcificación del anillo mitral

TAVR in general has better functional results in terms of patient/prosthesis mismatch. This seems especially true for patients with a small annulus. 

The TAVI-SMALL (International Multicenter Registry to Evaluate the Performance of Self-Expandable Valves in Small Aortic Annulus) is a retrospective study of aortic stenosis patients with small annuli (annulus perimeter <72 mm and annulus area <400 mm2) by CT and treated with self-expandable valves (Evolut R, n=397; Evolut PRO, n=84; ACURATE, n=201 and Portico, n=177). 

Primary endpoints were post-procedural mean aortic gradient, indexed effective orifice area, and rate of severe prosthesis-patient mismatch. 


Read also: Balloon-Expandable vs. Self-Expanding: To Each Valve Its Own Annulus.


Gradients were consistently low across groups with a small but significant benefit in favor of Evolut R (mean gradient 8.1 mmHg) and Evolut PRO (mean gradient 6.9 mmHg) compared with the ACURATE (mean gradient 9.6 mmHg) and the Portico (mean gradient 8.9 mmHg).

The indexed effective orifice area resulted 1.04 cm2/m2 with a trend to lower values for the Portico.

There were no significant differences as regards rates of mismatch (general 9.4%), need for pacemaker (15.6%) and periprocedural and one-year adverse events.


Read also: Small Aortic Annulus: What Valve Should We choose?


More than mild paravalvular leaks resulted more frequent with the Portico (19.2%) and less frequent with the Evolut PRO (3.6%), with intermediate values for Evolut R and Acurate.

Conclusion

The self-expandable valves most frequently used in the clinical practice showed optimal results, both clinic and echocardiographic, to treat patients with severe aortic stenosis and small annuli.  

Original title: Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli. The TAVI-SMALL Registry.

Reference: Damiano Regazzoli et al. J Am Coll Cardiol Intv 2019. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

TAVI in TAVI: Clinical and Hemodynamic Outcomes According to the Type of Prosthesis Used in TAVI-in-TAVI

With the expansion of TAVI to younger and lower surgical risk patients, bioprosthetic valve degeneration and the need for repeat interventions are expected to...

Percutaneous Closure of Patent Foramen Ovale in Patients Over 60 Years Old With Cryptogenic Stroke: A Safe and Effective Strategy?

Cryptogenic stroke accounts for up to one-third of all ischemic strokes and remains strongly associated with the presence of a patent foramen ovale (PFO),...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...